ARCHIVES

MSKCC oncologist settles insider trading case with SEC.

This article is from The Cancer Letter archive.

Vol. 31 No. 41 | November 11, 2005

Download PDF Visit The Full Archive

Related Articles

Afinitor Approved for Rare Disorder

November 5, 2010

NCI Has No Intention Of “Dismembering” Groups, Official Says

June 12, 1998

Carcinogenesis Program Direction Changes Near for Extramural research; Workshop Topics Listed

April 22, 1977

R.S.K. Young Quits As FDA Oncology Group Leader

July 11, 1980

In Brief: Senate Subcommittee Adds $100 Million For NCI Over House Bill, No Further Action Until Sept.

August 8, 1975

NIH Cool On OIG, But the Awardees Love it, DeVita Says

October 17, 1986